Author:
O’Donoghue Cristina,Zager Jonathan S.,Sondak Vernon K.
Reference125 articles.
1. Agarwala SS, Neuberg D, Park Y, Kirkwood JM (2004) Mature results of a phase III randomized trial of Bacillus Calmette–Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer stage I–III melanoma (E1673). Cancer 100(8):1692–1698
2. Agarwala SS, Thompson JF, Smithers BM, Ross MI, Coventry BJ, Minor DR et al (2010) Chemoablation of metastatic melanoma with rose bengal (PV-10). J Clin Oncol 28(15_suppl):8534
3. Agarwala SS, Thompson JF, Smithers BM, Ross MI, Scoggins CR, Coventry BJ et al (2014) Efficacy of intralesional Rose Bengal in patients receiving injection of all existing melanoma in phase II study PV-10-MM-02. J Clin Oncol 32(15_suppl):9027
4. Agarwala SS (2015) Intralesional therapy for advanced melanoma: promise and limitation. Curr Opin Oncol 27(2):151–156
5. Agarwala SS, Ross M Zager JS, Essner R, Shirai K, Smithers BM, Atkinson V, Wachter E (2017) Preliminary results of a Phase 1b/2 study of PV-10 and pembrolizumab in Stage IV melanoma. In: World Congress of Melanoma/Society for Melanoma Research Congress, Brisbane, 18 Oct 2017